Event Brief
Dec 9, 2025 at 9:07 AM ET
Postpartum depression pill gets approval in Canada
By The BriefBrief
Biogen's drug for postpartum depression is now approved in Canada, following its authorization in the U.S., U.K., and EU.
WHO: Biogen
WHAT: Approval of postpartum depression pill
WHEN: Dec 8, 2025 at 7:00 PM ET
WHERE: Canada
WHY: To provide treatment for postpartum depression
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21417 of 21417
Same format. Every time.
Continue reading — sign in or create a free account with
